XTX Topco Ltd Lowers Stake in Mettler-Toledo International Inc. (NYSE:MTD)

XTX Topco Ltd trimmed its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 88.8% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 199 shares of the medical instruments supplier's stock after selling 1,582 shares during the quarter. XTX Topco Ltd's holdings in Mettler-Toledo International were worth $298,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Mettler-Toledo International by 1.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 1,158 shares of the medical instruments supplier's stock valued at $1,619,000 after purchasing an additional 14 shares during the period. Fifth Third Wealth Advisors LLC acquired a new position in shares of Mettler-Toledo International in the second quarter worth about $368,000. Lecap Asset Management Ltd. acquired a new stake in shares of Mettler-Toledo International during the 2nd quarter valued at about $583,000. Slow Capital Inc. grew its position in shares of Mettler-Toledo International by 1.3% during the 2nd quarter. Slow Capital Inc. now owns 2,228 shares of the medical instruments supplier's stock valued at $3,113,000 after acquiring an additional 28 shares during the period. Finally, Family Firm Inc. purchased a new position in shares of Mettler-Toledo International in the 2nd quarter valued at about $25,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 140 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the sale, the insider now owns 6 shares of the company's stock, valued at approximately $7,524.54. The trade was a 95.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elisha W. Finney sold 76 shares of the company's stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the transaction, the director now owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company's stock.

Mettler-Toledo International Price Performance

NYSE MTD traded up $0.90 during trading hours on Wednesday, hitting $1,247.78. 22,365 shares of the company's stock traded hands, compared to its average volume of 134,887. The company has a market capitalization of $26.33 billion, a PE ratio of 33.74, a PEG ratio of 4.19 and a beta of 1.13. Mettler-Toledo International Inc. has a 52-week low of $1,115.64 and a 52-week high of $1,546.93. The firm's 50-day moving average is $1,297.64 and its 200-day moving average is $1,374.43.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The business had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Equities research analysts predict that Mettler-Toledo International Inc. will post 40.42 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have commented on MTD. Stifel Nicolaus dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a report on Monday, November 11th. Robert W. Baird dropped their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a "neutral" rating on the stock in a research note on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a "sell" rating to a "neutral" rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Friday, December 13th. They issued a "peer perform" rating on the stock. Finally, Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 1st. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $1,351.25.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.